-+ 0.00%
-+ 0.00%
-+ 0.00%

Chardan Capital Maintains Buy on Zura Bio, Maintains $10 Price Target

Benzinga·11/14/2025 20:54:31
Listen to the news
Chardan Capital analyst Daniil Gataulin maintains Zura Bio (NASDAQ:ZURA) with a Buy and maintains $10 price target.